Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.65206
+0.0321 (5.17%)
Nov 9, 2026, 2:14 PM EST
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $44.3 million as of November 9, 2026. It is the 31,110th most valuable company in the world and the 4,679th biggest in the United States. Its market cap has decreased by 10.27% in one year.
Market Cap
44.30M
Enterprise Value
46.21M
Revenue
n/a
Global Rank
Country Rank
#4,679 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 44.30M, an increase of 31.73%. That is a compound annual growth rate of 1.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 44.30M | -25.08% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 92.36M |
| Vaxart | 89.98M |
| ProText Mobility | 66.81M |
| Nuo Therapeutics | 51.82M |
| Sangamo Therapeutics | 47.23M |
| Cell Source | 35.80M |
| ZIVO Bioscience | 33.71M |
| Provectus Biopharmaceuticals | 22.27M |